Axon Enterprise ROA Ratio 2011-2026 | AXON

Annual ROA Ratio Axon Enterprise

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
1.78	8.43	5.16	5.15	-3.56	-0.12	0.1	4.06	1.54	6.22	8.67	10.75	12.3	12.68	-6.71	-3.22	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.68	-6.71	3.95

Quarterly ROA Ratio Axon Enterprise

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.39	3.67	4.79	6.03	4.59	4.99	4.82	3.73	6.37	7.64	10.18	8.68	8.68	5.6	-0.45	-3.55	-3.61	-8.79	-5.41	-2.0	-3.46	-2.67	-0.36	0.1	1.86	1.93	3.02	4.06	5.31	4.64	4.13	3.69	4.43	5.69	6.33	6.22	6.16	5.44	6.78	8.67	9.19	12.61	12.05	10.75	11.62	10.99	11.9	12.3	11.96	11.67	11.63	12.68	3.78	1.69	-3.45	-6.71	1.08	-2.19	0.02

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
12.68	-8.79	4.51

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-241.53	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-22.19	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	2.77	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	-41.16	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-142.36	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	-8.47	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	-179.56	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	8.97	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	20.2	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-114.6	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-40.14	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-0.8	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	2071.28	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-35.12	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-109.04	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	-25.67	$ 49.8	-	$ 4.48 B	Schweiz
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-77.89	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-207.62	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-43.36	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-44.38	$ 31.27	-	$ 2.08 B	USA
Generation Bio Co. GBIO	-56.95	-	-	$ 344 M	USA
IMV IMV	-121.19	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	36.63	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-102.69	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-36.68	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-5.72	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-48.33	-	5.93 %	$ 314 M	Canada
Enlivex Therapeutics Ltd. ENLV	53.1	$ 0.67	-	$ 30.6 M	Israel
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-19.87	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-103.3	$ 2.84	-	$ 4.68 M	Israel
Esperion Therapeutics ESPR	-4.87	$ 3.15	-	$ 655 M	USA
Forte Biosciences FBRX	-83.81	$ 17.56	-	$ 227 M	USA
Aptose Biosciences APTO	-254.37	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Eton Pharmaceuticals ETON	-4.99	$ 31.59	-	$ 850 M	USA
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-35.68	-	4.14 %	$ 49.1 M	USA